| Pharmaceutical active ingredients: |
| Oxymetazoline Hydrochloride |
| Available forms, composition and doses of Nostrilla 12 Hour Nasal Decongestant: |
| N / A |
| Nostrilla 12 Hour Nasal Decongestant medical category: |
| Human:Nasal decongestants and other nasal preparationsOphthalmic decongestants, anesthetics, anti-inflammatoriesVasoconstrictors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01AA05 - OxymetazolineR01AB07 - OxymetazolineS01GA04 - Oxymetazoline |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Newclar | Oxymetazoline Hydrochloride | ICN Pharmaceuticals |
| Nezeril | Oxymetazoline Hydrochloride | AstraZeneca |
| Noksprey | Oxymetazoline Hydrochloride | Sperko Ukraine |
| Nose-X | Oxymetazoline Hydrochloride | Pharmco Holdings |
| Nostrilla | Oxymetazoline Hydrochloride | Novartis |
| NTZ Long Acting Nasal | Oxymetazoline Hydrochloride | Bayer Schering Pharma |
| Ocuclear | Oxymetazoline Hydrochloride | Schering-Plough; Bayer Schering Pharma |
| Oftinal | Oxymetazoline Hydrochloride | Schering-Plough |
| Ordov Sinudec | Oxymetazoline Hydrochloride | OR-DOV Pharmaceuticals |
| Otrivin-O | Oxymetazoline Hydrochloride | Novartis |